Mackenzie Financial
XENT

Mackenzie Financial’s Intersect ENT, Inc XENT Stock Holding History

Mackenzie Financial’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-31,745
Closed -$1.19M – 1169
2018
Q2 		$1.19M Sell
31,745
-33,455
-51% -$1.31M ﹤0.01% 659
2018
Q1 		$2.56M Buy
65,200
+21,820
+50% +$797K 0.01% 532
2017
Q4 		$1.41M Buy
43,380
+1,220
+3% +$36.6K ﹤0.01% 570
2017
Q3 		$1.31M Buy
+42,160
New +$1.25M 0.01% 428
2016
Q2 		– Sell
-53,508
Closed -$1.02M – 959
2016
Q1 		$1.02M Sell
53,508
-9,482
-15% -$172K 0.01% 503
2015
Q4 		$1.42M Buy
62,990
+22,236
+55% +$440K 0.01% 474
2015
Q3 		$954K Sell
40,754
-7,106
-15% -$196K 0.01% 546
2015
Q2 		$1.37M Buy
47,860
+17,767
+59% +$466K 0.01% 504
2015
Q1 		$777K Buy
+30,093
New +$688K ﹤0.01% 589

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial's XENT Position: Q3 2018 in Review

Mackenzie Financial sold out of Intersect ENT, Inc (XENT) in Q3 2018, closing a stake of 31,745 shares — an estimated $1.19M sold.

Mackenzie Financial first reported a position in XENT in Q1 2015 and held it in 9 quarters. The position peaked at $2.56M in Q1 2018. 138 funds tracked by Wall St. Rank hold XENT as of Q3 2018.

  • Mackenzie Financial reported no remaining Intersect ENT, Inc position as of Q3 2018 after selling out during the quarter.
  • Mackenzie Financial sold 31,745 Intersect ENT, Inc shares in Q3 2018, an estimated $1.19M.
  • Mackenzie Financial first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 9 quarters.
  • Mackenzie Financial's Intersect ENT, Inc position peaked at $2.56M in Q1 2018.
  • 138 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2018.

Based on Mackenzie Financial's 13F filing for Q3 2018, filed 15 Nov 2018.